Evidence map›Paper›PMID 36700478›Full record

ArticleJournal of clinical neurology (Seoul, Korea)2023

Increased 10-Year Prevalence of Huntington's Disease in South Korea: An Analysis of Medical Expenditure Through the National Healthcare System.

Chan Young Lee, Jun-Soo Ro, Hyemin Jung, Manho Kim, Beomseok Jeon, Jee-Young Lee

Open access · diamondAbstract read
In one paragraph

Article in Journal of clinical neurology (Seoul, Korea), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. A Case of Late-Onset De Novo Huntington's Disease Diagnosed viaDementia and neurocognitive disorders · 2024
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Chan Young Lee *Department of Neurology, School of Medicine, Ewha Womans University Mokdong Hospital, Seoul, Korea.ORCID https://orcid.org/0000-0001-9559-5286
Jun-Soo Ro *Public Healthcare Center, Seoul National University Hospital, Seoul, Korea.ORCID https://orcid.org/0000-0002-8156-5294
Hyemin JungPublic Healthcare Center, Seoul National University Hospital, Seoul, Korea.ORCID https://orcid.org/0000-0001-7339-7983
Manho KimDepartment of Neurology, Seoul National University Hospital, Seoul, Korea.ORCID https://orcid.org/0000-0002-0277-6326
Beomseok JeonDepartment of Neurology, Seoul National University Hospital, Seoul, Korea.ORCID https://orcid.org/0000-0003-2491-3544
Jee-Young LeeDepartment of Neurology, Seoul National University Hospital, Seoul, Korea.ORCID https://orcid.org/0000-0002-6985-1730
Seoul National University Hospital · KREwha Womans University · KRNew Generation University College · ETSeoul National University · KR

Funding

Seoul Metropolitan Government Seoul National University Boramae Medical Center 04-2020-8
6 · The paper itself

Abstract

background and purposeThis study aimed to determine the updated 10-year prevalence of Huntington's disease (HD) in South Korea and the medical and economic burdens across the duration of the disease.

methodsData from the National Health Insurance database during 2010-2019 were analyzed. We identified HD cases using predefined criteria. Information on age at diagnosis, sex, and common nonneurological comorbidities were collected. We analyzed individual patterns of the use of medical services and yearly medical expenditure. Incidence rates, 10-year prevalence rates, and longitudinal medical expenditure changes were assessed.

resultsNew patients with HD (average=152.10) were detected every year, with an annual incidence of 0.29 per 100,000. The estimated 10-year prevalence of HD was 2.2 per 100,000. The most common ages at the time of diagnosis were 50-59 years (23.3%). In 2019, 56.4% of patients with HD were followed-up at referral or general hospitals, and 32.2% were managed at long-term-care hospitals. The annual medical cost for an individual was KRW 6,569,341±895,097 (mean±SD) (mean≈USD 5,653). Medical expenditure was the highest in those aged 60-79 years, and lowest in those younger than 30 years. However, in all age groups, the annual medical expenditure was highest during the 9 years following a diagnosis.

conclusionsThis study found that the actual prevalence of HD in South Korea was higher than previously thought and that patients are in a situation with high medical expenditure that persists over time.

Indexed as

epidemiologyHealth Insurance and Review AssessmentHuntington's diseasemedical expenditure

Identifiers

PMID36700478
PMCPMC9982180
OpenAlexW4318165721

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.